Study Investigates White Blood Cells in Heart Attack Recovery

Introduction to Cardiovascular Disease

A recent study published in Science Signaling explores the function of white blood cells in resolving inflammation after a heart attack. Cardiovascular disease remains the primary cause of illness and death in developed nations. Atherosclerosis, characterized by plaque accumulation in arterial vessels, is the leading contributor to cardiovascular disease and heightens the risk of myocardial infarction, commonly known as a heart attack. Inflammation marks a heart attack and, while it can facilitate healing, unresolved inflammation may result in heart failure. Gaining insight into the healing processes the body employs post-heart attack could be vital for developing innovative therapeutic strategies for individuals with cardiovascular conditions.

Role of Leukocytes in Inflammation Resolution

The study utilized a mouse model to examine how leukocytes, or white blood cells, participate in the phase of inflammation resolution. This process is active and coordinated, aiming to restore tissue integrity and function. Various leukocytes, such as neutrophils and monocytes/macrophages, migrate from the spleen to the left ventricle, playing a crucial role in healing and resolving inflammation. These infiltrating cells contribute to the resolution by generating specialized pro-resolving mediators (SPMs), including lipoxygenase (LOX) and cyclooxygenase (COX).

Immune System’s Role in Heart Attack Recovery

In the study, researchers induced heart attacks in mice through surgical ligation of the coronary artery, which cuts off blood and oxygen supply to the heart. They observed differences in gene expression for LOXs and COXs between the left ventricle and the spleen following a heart attack. Notably, genes encoding LOXs responsible for initiating SPM production were significantly more active in the left ventricle than in the spleen. This increase in LOX-encoding gene expression correlated with a heightened production of SPMs in the damaged left ventricle.

Analysis of Leukocyte Activation

Further analysis revealed that macrophage activation and infiltration were more pronounced in both the spleen and injured ventricles one day after the heart attack. By day five, macrophage accumulation was notably greater in the ventricles compared to the spleen. In contrast, neutrophil activation and infiltration peaked at day one and subsequently declined by day five in both organs, aligning with their role as first responders to injury. The findings indicate that while leukocytes are activated in both the spleen and injured ventricles post-myocardial infarction, SPM biosynthesis is more robust in the injured ventricles.

Phenotypic Properties of Leukocytes Post-Injury

The authors further examined the phenotypic characteristics of leukocytes following injury. They found that the number of resolving neutrophils was greater in the ventricle than in the spleen at both days one and five post-injury. Additionally, resolving macrophages increased at day one and peaked at day five in the ventricles compared to the spleen. These results suggest that leukocytes involved in inflammation resolution are more abundant in the ventricles after injury.

Conclusion and Future Directions

In summary, the study highlights significant temporal changes in the spleen and injured left ventricle following myocardial infarction. These findings enhance our understanding of the role leukocytes play in inflammation resolution after a heart attack. Future research is necessary to explore whether pharmacological restoration of SPMs can enhance inflammation resolution and improve health outcomes for patients with cardiovascular disease.

Reference

Halade, G. V., Norris, P. C., Kain, V., Serhan, C. N., & Ingle, K. A. (2018). Splenic leukocytes define the resolution of inflammation in heart failure. Sci. Signal., 11(520), eaao1818.